Holen Sie sich die Stockscreener-App
7.69
11.05%
0.765
Vorhandelsmarkt:
7.69
Schlusskurs vom Vortag:
$6.925
Offen:
$6.73
24-Stunden-Volumen:
37,219
Relative Volume:
0.13
Marktkapitalisierung:
$24.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-68.80M
KGV:
-6.5726
EPS:
-1.17
Netto-Cashflow:
$-59.06M
1W Leistung:
+20.53%
1M Leistung:
+38.31%
6M Leistung:
+1,298%
1J Leistung:
+953.42%
1-Tages-Spanne:
$6.73
$7.75
1-Wochen-Bereich:
$6.50
$7.75
52-Wochen-Spanne:
$0.257
$7.75
Passage Bio Inc Stock (PASG) Company Profile
Firmenname
Passage Bio Inc
Sektor
Branche
Telefon
(267) 866-0312
Adresse
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Vergleichen Sie PASG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
7.69 | 22.95M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.36 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.01 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.31 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.97 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.33 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-29 | Fortgesetzt | Wedbush | Outperform |
| 2024-09-03 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-03-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-01-19 | Herabstufung | Goldman | Buy → Neutral |
| 2021-07-01 | Eingeleitet | Raymond James | Outperform |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-03-04 | Hochstufung | Goldman | Neutral → Buy |
| 2021-02-04 | Eingeleitet | Guggenheim | Buy |
| 2021-01-25 | Eingeleitet | Wedbush | Outperform |
| 2021-01-04 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-11 | Eingeleitet | Citigroup | Neutral |
| 2020-08-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-06-25 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-25 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-03-24 | Eingeleitet | Cowen | Outperform |
| 2020-03-24 | Eingeleitet | Goldman | Buy |
| 2020-03-24 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Passage Bio Inc Aktie (PASG) Neueste Nachrichten
How high can Passage Bio Inc. stock go2025 Price Momentum & Breakout Confirmation Alerts - Newser
Will Passage Bio Inc. stock go up soon2025 Market Overview & Trade Opportunity Analysis - Newser
Real time alert setup for Passage Bio Inc. performanceJuly 2025 Reactions & Free Reliable Trade Execution Plans - Newser
Backtesting results for Passage Bio Inc. trading strategiesPortfolio Risk Summary & Low Risk Entry Point Tips - Newser
Is a relief rally coming for Passage Bio Inc. holdersSell Signal & AI Powered Market Entry Strategies - Newser
Should you hold or exit Passage Bio Inc. now2025 Market Overview & Verified High Yield Trade Plans - Newser
Recovery Setup Building in Passage Bio Inc. Experts Say2025 Volume Leaders & Safe Entry Trade Signal Reports - thegnnews.com
Identifying reversal signals in Passage Bio Inc.Trade Analysis Summary & Verified Stock Trade Ideas - Newser
What to do if you’re stuck in Passage Bio Inc.Layoff News & Smart Swing Trading Techniques - Newser
What indicators show strength in Passage Bio Inc.Quarterly Market Summary & Real-Time Volume Analysis Alerts - Newser
Quantitative breakdown of Passage Bio Inc. recent moveJuly 2025 Opening Moves & Detailed Earnings Play Strategies - Newser
Chart based exit strategy for Passage Bio Inc.2025 EndofYear Setup & Safe Entry Zone Tips - Newser
What MACD signals say about Passage Bio Inc.Quarterly Portfolio Review & Precise Trade Entry Recommendations - Newser
Developing predictive dashboards with Passage Bio Inc. dataQuarterly Profit Review & AI Powered Market Trend Analysis - Newser
Visual analytics tools that track Passage Bio Inc. performanceTrade Signal Summary & Daily Profit Focused Stock Screening - Newser
Understanding Passage Bio Inc.’s price movementQuarterly Trade Summary & Verified Entry Point Signals - Newser
Leading vs lagging indicators on Passage Bio Inc. performance2025 Earnings Impact & Weekly Market Pulse Updates - Newser
Passage Bio Inc. stock outlook for YEARJuly 2025 Macro Moves & Community Verified Swing Trade Signals - Newser
Published on: 2025-08-18 01:07:01 - Newser
Sentiment analysis tools applied to Passage Bio Inc.Quarterly Trade Summary & Step-by-Step Trade Execution Guides - Newser
Forecasting Passage Bio Inc. price range with options dataSwing Trade & Community Trade Idea Sharing - Newser
Will Passage Bio Inc. Stock Benefit from AI and Green Energy TrendsWeekly Trade Analysis & Safe Swing Trade Setups - Newser
Strategies to average down on Passage Bio Inc.Portfolio Risk Report & Fast Gain Swing Alerts - Newser
Technical signs of recovery in Passage Bio Inc.Market Growth Summary & Free Fast Gain Swing Trade Alerts - Newser
What analysts say about Passage Bio Inc. stock outlookOptions Play & Weekly Return Optimization Plans - Newser
Why Passage Bio Inc. stock attracts strong analyst attentionWeekly Trade Report & Real-Time Buy Zone Alerts - Newser
Should I buy Passage Bio Inc. stock now2025 Geopolitical Influence & Verified Momentum Watchlists - mustnews.co.kr
Is Passage Bio Inc. Stock a Good Fit for Conservative InvestorsBond Market & Community Shared Stock Ideas - Newser
Published on: 2025-08-16 04:23:20 - Newser
Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade - MSN
Wedbush Comments on Passage Bio’s Q3 Earnings (NASDAQ:PASG) - Defense World
What moving averages say about Passage Bio Inc.Insider Buying & Expert Verified Stock Movement Alerts - Newser
Passage Bio Inc. stock volume spike explainedEarnings Performance Report & Reliable Breakout Forecasts - Newser
Guggenheim Maintains Buy Rating on Passage Bio with $10 Price Target - AInvest
Passage Bio (NASDAQ:PASG) Given New $67.00 Price Target at Canaccord Genuity Group - Defense World
Wedbush Forecasts Strong Price Appreciation for Passage Bio (NASDAQ:PASG) Stock - Defense World
Passage Bio (PASG) and the 1,415.15% Upside Potential in Biotech Innovation - AInvest
Wedbush Increases Passage Bio (NASDAQ:PASG) Price Target to $40.00 - Defense World
Finanzdaten der Passage Bio Inc-Aktie (PASG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Passage Bio Inc-Aktie (PASG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10% Owner |
Jul 23 '25 |
Buy |
5.74 |
49,302 |
283,033 |
525,273 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 22 '25 |
Buy |
5.44 |
13,123 |
71,338 |
475,971 |
2.44%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):